Ԗ[uiHanafusa Tadashij

<2006>


<2005>

Hanafusa T, Shinji T, Shiraha H, Nouso K, Iwasaki Y, Yumoto E, Ono T and Koide N: Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation. BMC Cancer (2005) 5, 9

Uematsu S, Higashi T, Nouso K, Kariyama K, Nakamura S, Suzuki M, Nakatsukasa H, Kobayashi Y, Hanafusa T, Tsuji T and Shiratori Y: Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma. J Gastroenterol Hepatol (2005) 20, 583-8.

Yumoto E, Nakatsukasa H, Hanafusa T, Yumoto Y, Nouso K, Matsumoto E, Onishi T, Takuma H, Fujikawa T, Suzuki M, Uemura M and Shiratori Y: IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways. Int J Oncol (2005) 27, 1223-30.


<2004>

Fujiwara K, Higashi T, Nouso K, Nakatsukasa H, Kobayashi Y, Uemura M, Nakamura S, Sato S, Hanafusa T, Yumoto Y, Naito I and Shiratori Y : Decreased expression of B7 costimulatory molecules and major histocompatibility complex class-l in human hepatocellular carcinoma. J Gastroenterol Hepatol (2004) 19, 1121-7.

Takuma Y, Nouso K, Kobayashi Y, Nakamura S, Tanaka H, Matsumoto E, Fujikawa T, Suzuki M, Hanafusa T and Shiratori Y: Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma. J Gastroenterol Hepatol (2004) 19, 1300-4.


<2003>

Uemura M, Nouso K, Kobayashi Y, Tanaka H, Nakamura S, Higashi T, Ono T, Nakayama E, Hanafusa T and Shiratori Y : Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma. Cancer (2003) 97, 2474-2479.

Onishi T, Nouso K, Higashi T, Toshikuni N, Nakatsukasa H, Kobayashi Y, Uemura M, Yumoto E, Fujiwara K, Sato S, Nakamura S, Yokoyama@J, Hanafusa T and Shiratori Y: Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma. J Gastroenterol Hepatol (2003) 18, 1168-1174.


<2002>

Hanafusa T, Yumoto Y, Mimura T, Shinji T, Hada H, Koide N, and Tsuji T: Genome aberrations observed by restriction landmark genome scanning analysis of chromosomal DNA in various types of primary hepatocellular carcinoma. Hepato-Gastroenterol (2002) 49, 490-494.

Hanafusa T, Yumoto Y, Nouso K, Nakatsukasa H, Onishi T, Fujikawa T, Taniyama M, Nakamura S, Uemura M, Takuma Y, Yumoto E, Higashi T, and Tsuji T: Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. Can lett (2002) 176, 149-158.

Yumoto E, Higashi T, Nouso K, Nakatsukasa H, Fujiwara K, Hanafusa T, Yumoto Y, Tanimoto T, Kurimoto M, Tanaka N, Tsuji T: Serum gamma-interferon-inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure. J Gastroenterol Hepatol (2002) 17, 285-294.

Takahashi A, Iwasaki Y, Miyaike J, Taniguchi H, Shimomura H, Hanafusa T, Yumoto Y, Moriya A, Koide N, Tsuji T: Quantitative analysis of p40/p46 and p69/p71 forms of 2',5'-oligoadenylate synthetase mRNA by competitive PCR and its clinical application. Clin Chem (2002) 48, 1551-1559.